$169.182,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

In this issue of Neurologic Clinics, guest editor Dr. Carrie M. Hersh brings her considerable expertise to the topic of Multiple Sclerosis. Top experts in the field discuss diagnosis and pathophysiology concepts, treatment, special populations in MS, and contemporary issues related to MS.

  • Contains 18 relevant, practice-oriented topics including recent advances in diagnostic, prognostic, and disease monitoring biomarkers in MS; the growing problem of MS misdiagnosis; highly effective therapy versus escalation approaches in early MS; clinical considerations in the diagnosis, management, and treatment of MS in Black and Latinx populations; women’s health and pregnancy in MS; the era of COVID-19 in MS care; and more.
  • Provides in-depth clinical reviews on multiple sclerosis, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Multiple Sclerosis Diagnostic Delay and Misdiagnosis - p. 1 9. Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis - p. 15 10. Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA - p. 39 11. Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment - p. 55 12. Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders - p. 77 13. Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies - p. 115 14. Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion - p. 137 15. Bruton’s Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier - p. 155 16. Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis - p. 165 17. Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment? - p. 185 18. Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis - p. 203 19. Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable - p. 229 20. Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis - p. 255 21. Women’s Health and Pregnancy in Multiple Sclerosis - p. 275 22. Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved - p. 295 23. Era of COVID-19 in Multiple Sclerosis Care - p. 319

Descripcion
Descripción

In this issue of Neurologic Clinics, guest editor Dr. Carrie M. Hersh brings her considerable expertise to the topic of Multiple Sclerosis. Top experts in the field discuss diagnosis and pathophysiology concepts, treatment, special populations in MS, and contemporary issues related to MS.

  • Contains 18 relevant, practice-oriented topics including recent advances in diagnostic, prognostic, and disease monitoring biomarkers in MS; the growing problem of MS misdiagnosis; highly effective therapy versus escalation approaches in early MS; clinical considerations in the diagnosis, management, and treatment of MS in Black and Latinx populations; women’s health and pregnancy in MS; the era of COVID-19 in MS care; and more.
  • Provides in-depth clinical reviews on multiple sclerosis, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Multiple Sclerosis Diagnostic Delay and Misdiagnosis - p. 1 9. Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis - p. 15 10. Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA - p. 39 11. Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment - p. 55 12. Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders - p. 77 13. Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies - p. 115 14. Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion - p. 137 15. Bruton’s Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier - p. 155 16. Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis - p. 165 17. Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment? - p. 185 18. Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis - p. 203 19. Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable - p. 229 20. Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis - p. 255 21. Women’s Health and Pregnancy in Multiple Sclerosis - p. 275 22. Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved - p. 295 23. Era of COVID-19 in Multiple Sclerosis Care - p. 319

Indice
Autores
Muestra
Ficha Técnica